How Lonza Capsules & Health Ingredients (CHI) is redefining drug delivery with cutting-edge capsule innovation, ...

Roche is set to raise $1.2 billion from the sale of a US biologics manufacturing facility to Swiss contract development and manufacturing organisation (CDMO) Lonza, part of a drive to match ...

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical ... It operates through Biologics; Small Molecules; Cell & Gene; and Capsules & Health ...

Before proving our financials changes, in our base case scenario, we continue to assume that the global biologics market should grow at a double-digit pace in the future. Lonza has compelling long ...

Under the terms of the new agreement, Lonza will manufacture the mAb at Lonza’s biologics facility in Porriño (ES), occupying a majority of the site’s manufacturing capacity. The ADC will then be ...

Lonza Group posted lower sales and earnings ... sales fell 2.1% to 6.57 billion Swiss francs ($7.27 billion) as growth in its ...